• News
  • SAN DIEGO
  • BioTech

Halozyme price jumps 17%

Shares in Halozyme Therapeutics (Nasdaq: HALO) jumped nearly 17 percent on Wednesday and added another 1 percent in morning trading on Thursday after announcing it was naming Helen Torley to replace Gregory Frost as CEO.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!